poisar

Stocks · News reference

Chewy Posts In-Line Q2 Earnings: Pet Parents Cut Treats, Not Necessities

BenzingaPriya Nigam

Chewy Q2 sales rose 7.3% to $3.33B; guidance raised. Analysts cited weak discretionary demand and a mixed outlook.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolSara Appino

    Advanced Micro Devices vs. Nvidia: Which Semiconductor Stock Is a Better Buy in 2026?

    The article compares AMD and Nvidia as AI chip investments for 2026. While AMD shows strong growth with 34.3% revenue increase and successful partnerships, Nvidia dominates with 65.5% revenue growth, 55.6% net margins, and $96.7B in free cash flow. The author recommends Nvidia for long-term investors due to its superior scale, ecosystem depth, and industry lock-in, though AMD is presented as a reasonable lower-priced alternative.

  2. The Motley FoolSara Appino

    BigBear.ai vs. Innodata: Which Technology Stock Is a Better Buy in 2026?

    The article compares two AI-focused service providers: BigBear.ai, which provides decision intelligence for government and defense sectors, and Innodata, which offers data engineering services for generative AI models. While BigBear.ai faces revenue decline and significant losses, Innodata demonstrates strong growth with 12 consecutive quarters of year-over-year revenue increases and improved profitability. The analyst recommends Innodata as the stronger pick for 2026, citing its execution and improving business quality, though both companies face customer concentration risks.

  3. The Motley FoolJeremy Bowman

    Is Chewy a Buy After Its Latest Earnings Report?

    Chewy stock fell 11% despite meeting Q2 earnings expectations and raising full-year guidance, as management signaled weak consumer demand for premium pet products and add-on purchases. The company's growth has slowed significantly from its pandemic-era boom, and it now resembles a mature consumer staples business rather than a high-growth disruptor. The analyst recommends avoiding the stock until it demonstrates faster organic growth.